Another fact was that SARS-CoV might also use different receptors to enter the host cell and the possible effects of statin, mainly via inhibition of special receptors such as LDL-receptors (LDL-R) (Khademi et al., 2018), resulting in the absence of any beneficial biological effect regarding statin therapy on the COVID-19. The gene discussed is LDLR; the disease is COVID-19.